StockData
CERo Therapeutics Holdings, Inc. logo

CERo Therapeutics Holdings, Inc. (CERO) stock

CEROOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CEROW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.01+0.00 (0.00%)

Close on Oct 19, 2026Market cap $253.05KP/E –Yield 172833.33%

CERo Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

CERo Therapeutics's market cap was $811.76K on Apr 30, 2024.

Market Cap at the end of each year

PeriodPeriod endValueChange
2024Apr 30, 2024$811.76K–

More CERo Therapeutics figures

See a number that looks wrong?